Insulin Signaling Mechanisms in Cellular Systems

Insulin signalling underpins the regulation of metabolic homeostasis, growth and cellular survival. At its core is the insulin receptor (IR), a covalent αβ₂ homodimeric tyrosine kinase that undergoes conformational changes upon hormone binding. Insulin engages two distinct extracellular sites, triggering structural rearrangements that bring the transmembrane domains into proximity and enable autophosphorylation of intracellular kinase domains. This initiates the recruitment of adaptor proteins such as IRS-1 and Shc, leading to activation of parallel cascades: the PI3K–Akt pathway, which regulates glucose uptake and lipid synthesis, and the Ras–MAPK pathway, which governs cell proliferation and gene expression. Negative cooperativity in ligand binding and isoform-specific differences (IR-A versus IR-B) modulate signalling amplitude and duration. Fine-tuning is achieved through receptor internalisation, trafficking and feedback via phosphatases and ubiquitin ligases. Dysregulation of these processes contributes to insulin resistance, type 2 diabetes and cancer. Recent advances in cryo-electron microscopy, chemical biology and biased agonist design have delivered unprecedented structural and functional insights, offering new avenues for selective modulation of metabolic versus mitogenic outputs and the development of next-generation insulin analogues and receptor inhibitors.

Research from Nature Portfolio

Recent studies have elucidated the molecular basis of insulin receptor activation. High-resolution cryo-EM structures of the full-length receptor bound to insulin-like growth factor 2 reveal that IGF2 induces predominantly asymmetric conformations with ligands occupying two distinct sites, explaining its lower potency relative to insulin and delineating the role of the α-CT segment in modulating binding kinetics and receptor trafficking. Complementary work has visualised the ligand-bound IR ectodomain in a T-shaped active conformation, demonstrating how single insulin occupancy stabilises membrane-proximal domain dimerisation and negative cooperativity, thereby providing a structural platform for rational design of super-mitogenic and long-acting insulin analogues.

Insulin Signaling Mechanisms in Cellular Systems publication trend

The graph below shows the total number of articles in insulin signaling mechanisms in cellular systems across all publications each year (not limited to Nature Index journals).

Technical terms

Autophosphorylation: Intramolecular phosphorylation of kinase domains enabling full receptor activation.

Negative cooperativity: A decrease in binding affinity for additional ligands once one site is occupied.

Ectodomain: The extracellular portion of a membrane receptor responsible for ligand binding.

Juxtamembrane region: The segment immediately adjacent to the transmembrane helix, often critical for substrate recruitment.

Biased agonist: A ligand that preferentially activates one downstream pathway over others.

References

1. The Activation Mechanism of the Insulin Receptor: A Structural Perspective. Annual Review of Biochemistry (2023).
2. Activation of the insulin receptor by insulin-like growth factor 2. Nature Communications (2024).
3. The signalling conformation of the insulin receptor ectodomain. Nature Communications (2018).
4. A stepwise activation model for the insulin receptor. Experimental & Molecular Medicine (2023).
5. Leucine-973 is a crucial residue differentiating insulin and IGF-1 receptor signaling. Journal of Clinical Investigation (2023).